| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/11/2010 | WO2010128525A2 A formulation of ivabradine for treating the cardiovascular disease |
| 11/11/2010 | WO2010128465A1 Prevention and treatment of nosema disease in bees |
| 11/11/2010 | WO2010128450A1 Novel acylated decasaccharides and their use as antithrombotic agents |
| 11/11/2010 | WO2010128448A1 Use of an acylated octasaccharide as antithrombotic agent |
| 11/11/2010 | WO2010128446A1 Novel acylated 1,6-anhydro decasaccharide and its use as antithrombotic agent |
| 11/11/2010 | WO2010128443A1 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer |
| 11/11/2010 | WO2010128425A1 Gpr 119 modulators |
| 11/11/2010 | WO2010128414A1 Gpr 119 modulators |
| 11/11/2010 | WO2010128401A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| 11/11/2010 | WO2010128345A1 Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache |
| 11/11/2010 | WO2010128324A1 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 |
| 11/11/2010 | WO2010128309A1 Combination therapy comprising a taxane and a sigma receptor ligand sauch as rimcazole |
| 11/11/2010 | WO2010128300A1 Composition for sustained drug delivery comprising geopolymeric binder |
| 11/11/2010 | WO2010128259A1 Antitumor combination including ave8062 and sorafenib |
| 11/11/2010 | WO2010128258A1 Antitumor combination including cabazitaxel and capecitabine |
| 11/11/2010 | WO2010128191A1 Bivalent pyrazole derivatives as food intake inhibitors |
| 11/11/2010 | WO2010128156A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication |
| 11/11/2010 | WO2010128152A1 Fused heterocyclic c-glycosides for the treatment of diabetes |
| 11/11/2010 | WO2010128111A1 Concentrated mast cell stabilizing pharmaceutical formulations |
| 11/11/2010 | WO2010128102A1 Carboxamide compounds and their use as calpain inhibitors |
| 11/11/2010 | WO2010128061A1 Novel isoquinoline derivatives |
| 11/11/2010 | WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors |
| 11/11/2010 | WO2010128050A2 Anti-inflammatory agents as virostatic compounds |
| 11/11/2010 | WO2010128038A1 Hydroquinone derivatives |
| 11/11/2010 | WO2010127978A1 Isoxazole-pyridine derivatives as gaba modulators |
| 11/11/2010 | WO2010127976A1 Isoxazole-pyridine derivatives |
| 11/11/2010 | WO2010127975A1 Isoxazole-pyrazole derivatives |
| 11/11/2010 | WO2010127974A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders |
| 11/11/2010 | WO2010127878A2 Use of thiabendazole and derivatives thereof for the theraphy of neurological conditions |
| 11/11/2010 | WO2010127856A1 Substituted phenyllureas and phenylamides as vanilloid receptor ligands |
| 11/11/2010 | WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| 11/11/2010 | WO2010127754A1 3-([1,2,3]triazole-4-yl)-pyrrolo[2,3-b]pyridine derivates |
| 11/11/2010 | WO2010127674A1 Transdermal compositions of asenapine for the treatment of psychiatric disorders |
| 11/11/2010 | WO2010127608A1 Heterocyclic substituted acardite derivates and use thereof |
| 11/11/2010 | WO2010127600A1 6-deoxidized sulfone cyclodextrin derivatives and preparation method thereof |
| 11/11/2010 | WO2010127558A1 Substituted benzoyl urea compounds, preparation methods and uses thereof |
| 11/11/2010 | WO2010127557A1 Use of lanostanes and extracts from poria cocos for treating cachexia |
| 11/11/2010 | WO2010127541A1 A nano-emulsion injection of vinca alkaloids and the preparation method thereof |
| 11/11/2010 | WO2010127470A1 Paeoniflorin preparations and uses thereof for fat reduction |
| 11/11/2010 | WO2010127452A1 5-oxo-ete receptor antagonist compounds |
| 11/11/2010 | WO2010127448A1 Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof |
| 11/11/2010 | WO2010127443A1 Inhibitors of sialidase or sialidase-like enzymes |
| 11/11/2010 | WO2010127440A1 Substituted aromatic compounds and pharmaceutical uses thereof |
| 11/11/2010 | WO2010127439A1 Ammo acid derivatives for the treatment of neuropathic pain |
| 11/11/2010 | WO2010108051A3 Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof |
| 11/11/2010 | WO2010107952A3 RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 11/11/2010 | WO2010105179A3 Inhibitors of beta-secretase |
| 11/11/2010 | WO2010101967A3 Phosphothiophene and phosphothiazole hcv polymerase inhibitors |
| 11/11/2010 | WO2010101353A3 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer |
| 11/11/2010 | WO2010097471A3 Protein targets in disease |
| 11/11/2010 | WO2010097229A3 Amorphous salt of a macrocyclic inhibitor of hcv |
| 11/11/2010 | WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor |
| 11/11/2010 | WO2010094837A3 Sugar product |
| 11/11/2010 | WO2010094733A3 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 11/11/2010 | WO2010093705A3 Synthetic rna-based agonists of tlr7 |
| 11/11/2010 | WO2010093436A3 Toll-like receptor modulators and treatment of diseases |
| 11/11/2010 | WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors |
| 11/11/2010 | WO2010091894A3 Methods of treating hair related conditions |
| 11/11/2010 | WO2010091649A3 A composition for buccal absorption of nicotine for the purpose of smoking cessation |
| 11/11/2010 | WO2010086129A8 Inclusion complex comprising cinacalcet and cyclodextrin |
| 11/11/2010 | WO2010080712A3 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 11/11/2010 | WO2010079978A3 Composition for improving inflammatory disease using abh antigens |
| 11/11/2010 | WO2010077074A3 Preparation for the treatment of diabetes comprising arginine thiazolidine carboxylate or a derivative thereof |
| 11/11/2010 | WO2010074587A3 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use |
| 11/11/2010 | WO2010074540A3 Pharmaceutical composition containing an anionic drug, and a production method therefor |
| 11/11/2010 | WO2010054138A3 Modulators of atp-binding cassette transporters |
| 11/11/2010 | WO2010042886A3 Pyrones for the treatment of metabolic disorders |
| 11/11/2010 | WO2010032269A3 Anti-inflammatory activity of the iridoid glycosides |
| 11/11/2010 | WO2010001179A3 Calcium ion channel modulators & uses thereof |
| 11/11/2010 | WO2009152052A8 Methods of treating alpha adrenergic mediated conditions |
| 11/11/2010 | WO2009141091A8 Novel [f-18] -labelled l-glutamic acid- and l-glutamine derivatives (i), use thereof and method for their production |
| 11/11/2010 | WO2009121939A3 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 11/11/2010 | WO2009092516A3 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 11/11/2010 | WO2009073497A3 Prolyl hydroxylase inhibitors |
| 11/11/2010 | WO2009018338A3 Phosphorylated pyrone analogs and methods |
| 11/11/2010 | WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 11/11/2010 | WO2009009001A9 Crystalline pyridazine compound |
| 11/11/2010 | WO2008148080A8 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin] |
| 11/11/2010 | WO2008120241A3 Novel alcohol solvates of perindopril erbumine |
| 11/11/2010 | WO2007143597A9 Organic compounds |
| 11/11/2010 | WO2004062646A9 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 11/11/2010 | US20100287637 Methods of blocking tissue destruction by autoreactive t cells |
| 11/11/2010 | US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 11/11/2010 | US20100286786 Bioadhesive hydrogels |
| 11/11/2010 | US20100286630 Method For Treating Overactive Bladders And A Device For Storage And Administration Of Topical Oxybutynin Compositions |
| 11/11/2010 | US20100286600 Transdermal patch device |
| 11/11/2010 | US20100286589 Atherosclerotic Plaque Dissolution Composition |
| 11/11/2010 | US20100286386 Combinatorial production of nucleotide and nucleoside (XiTP) analogues |
| 11/11/2010 | US20100286384 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 11/11/2010 | US20100286285 Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state |
| 11/11/2010 | US20100286284 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphthalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde as medicaments |
| 11/11/2010 | US20100286283 Microtubule-disruptng agent and cancer cell proliferation inhibitor containing the same |
| 11/11/2010 | US20100286282 Exo-s-mecamylamine formulation and use in treatment |
| 11/11/2010 | US20100286281 Methods and materials for the treatment of testosterone deficiency in men |
| 11/11/2010 | US20100286280 Inhibitors of eppin/semenogelin binding as male contraceptives |
| 11/11/2010 | US20100286279 Methods of Synthesis of Certain Hydroxamic Acid Compounds |
| 11/11/2010 | US20100286278 Composition comprising an HDAC inhibitor in combination with a retinoid |
| 11/11/2010 | US20100286277 Method to enhance aqueous solubility of poorly soluble actives |
| 11/11/2010 | US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 11/11/2010 | US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |